Last $12.88 USD
Change Today -0.43 / -3.23%
Volume 169.7K
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

genmark diagnostics inc (GNMK) Snapshot

Open
$13.17
Previous Close
$13.31
Day High
$13.41
Day Low
$12.85
52 Week High
01/5/15 - $14.40
52 Week Low
05/21/14 - $8.48
Market Cap
537.5M
Average Volume 10 Days
119.5K
EPS TTM
$-0.93
Shares Outstanding
41.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENMARK DIAGNOSTICS INC (GNMK)

Related News

No related news articles were found.

genmark diagnostics inc (GNMK) Related Businessweek News

No Related Businessweek News Found

genmark diagnostics inc (GNMK) Details

GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company’s products include XT-8 system, an automated molecular diagnostic system that enables reference laboratories and hospitals to perform molecular diagnostic tests. It also offers 8 diagnostic tests for use with its XT-8 system that includes Cystic Fibrosis Genotyping Test, which detects a panel of mutations associated with cystic fibrosis; Warfarin Sensitivity test that determines an individual’s ability to metabolize the oral anticoagulant warfarin; Thrombophilia Risk Test, which detects an individual’s increased risk of blood clots; and Respiratory Viral Panel test that simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illnesses. The company’s diagnostic tests also include Hepatitis C Virus Genotyping test for the detection and typing/subtyping of HCV; 3A4/3A5 Genotyping test designed for the detection and genotyping of the alleles of the CYP450 3A4 gene locus and CYP450 3A5 gene locus; and 2C19 Genotyping test for the detection and genotyping alleles of the cytochrome P450 (CYP450) 2C19 gene locus. In addition, the company is engaged in developing a NexGen system to integrate automated nucleic acid extraction and amplification with its eSensor detection technology to enable technicians to place a patient sample into test cartridge and obtain results without any additional steps. Genmark Diagnostics, Inc. is headquartered in Carlsbad, California.

153 Employees
Last Reported Date: 03/11/14

genmark diagnostics inc (GNMK) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $450.0K
Senior Vice President of North American Comme...
Total Annual Compensation: $226.2K
Senior Vice President of International
Total Annual Compensation: $154.8K
Senior Vice President of Human Resources
Total Annual Compensation: $248.1K
Compensation as of Fiscal Year 2013.

genmark diagnostics inc (GNMK) Key Developments

GenMark Diagnostics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2014

GenMark Diagnostics, Inc. provided revenue guidance for the fourth quarter and full year of 2014. For the fourth quarter, the company expects fourth quarter 2014 revenue of $9.8 million, an increase of 52% over the prior year period. Full year 2014 revenue is expected to be $30.6 million, an increase of 59% against 2013 base business revenue, which excludes former customer NMTC.

GenMark Diagnostics, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 09:30 AM

GenMark Diagnostics, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 09:30 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Hany Massarany, Chief Executive Officer, President and Director.

GenMark Diagnostics, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 09:30 AM

GenMark Diagnostics, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 09:30 AM. Venue: The Westin Grand Central, New York, New York, United States. Speakers: Scott Mendel, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNMK:US $12.88 USD -0.43

GNMK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cepheid $56.51 USD +2.42
Hologic Inc $30.37 USD -0.75
Luminex Corp $17.65 USD -0.25
QIAGEN NV €20.31 EUR -0.25
Sequenom Inc $3.68 USD 0.00
View Industry Companies
 

Industry Analysis

GNMK

Industry Average

Valuation GNMK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 19.6x
Price/Book 6.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 16.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENMARK DIAGNOSTICS INC, please visit www.genmarkdx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.